These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 31579041)

  • 41. Salvage high-intensity focused ultrasound ablation for prostate cancer local recurrence after external-beam radiation therapy: prognostic value of prostate MRI.
    Rouvière O; Sbihi L; Gelet A; Chapelon JY
    Clin Radiol; 2013 Jul; 68(7):661-7. PubMed ID: 23485154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study.
    Clery R; Grande P; Seisen T; Gobert A; Duquesne I; Villers A; Olivier J; Bernhard JC; Robert G; Beauval JB; Prudhomme T; Bruyère F; Lainé-Caroff P; Waltregny D; Guillonneau B; Panarello D; Ruffion A; De Bayser H; de La Taille A; Roupret M
    World J Urol; 2019 Aug; 37(8):1491-1498. PubMed ID: 30790014
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and internal validation of prediction models for biochemical failure and composite failure after focal salvage high intensity focused ultrasound for local radiorecurrent prostate cancer: Presentation of risk scores for individual patient prognoses.
    Peters M; Kanthabalan A; Shah TT; McCartan N; Moore CM; Arya M; van der Voort van Zyp JR; Moerland MA; Hindley RG; Emberton M; Ahmed HU
    Urol Oncol; 2018 Jan; 36(1):13.e1-13.e10. PubMed ID: 28927782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancer.
    Dickinson L; Ahmed HU; Hindley RG; McCartan N; Freeman A; Allen C; Emberton M; Kirkham AP
    Urol Oncol; 2017 Jan; 35(1):30.e9-30.e15. PubMed ID: 27663393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experience with high-intensity focused ultrasound therapy for management of organ-confined prostate cancer: critical evaluation of oncologic outcomes.
    Komura K; Inamoto T; Masuda H; Watsuji T; Azuma H
    Acta Biomed; 2012 Dec; 83(3):189-96. PubMed ID: 23762994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
    Lee HM; Hong JH; Choi HY
    Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between Lesion Location and Oncologic Outcomes after Focal Therapy for Localized Prostate Cancer Using Either High Intensity Focused Ultrasound or Cryotherapy.
    Stabile A; Sanchez-Salas R; Tourinho-Barbosa R; Macek P; Pellegrino F; Gandaglia G; Moschini M; Cathala N; Mombet A; Montorsi F; Briganti A; Cathelineau X
    J Urol; 2021 Sep; 206(3):638-645. PubMed ID: 33890485
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.
    Challacombe BJ; Murphy DG; Zakri R; Cahill DJ
    BJU Int; 2009 Jul; 104(2):200-4. PubMed ID: 19220245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Salvage Hemiablation High Intensity Focused Ultrasound for unilateral radio-recurrent prostate cancer.
    Aoun F; Albisinni S; Biaou I; Peltier A; Limani K; Roumeguère T; van Velthoven R
    Prog Urol; 2019 Oct; 29(12):627-633. PubMed ID: 31400963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single-session primary high-intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation-based technology.
    Pinthus JH; Farrokhyar F; Hassouna MM; Woods E; Whelan K; Shayegan B; Orovan WL
    BJU Int; 2012 Oct; 110(8):1142-8. PubMed ID: 22372721
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-Whole-Gland High-Intensity Focused Ultrasound vs Whole-Gland High-Intensity Focused Ultrasound for Management of Localized Prostate Cancer: 1-Year Oncological and Functional Outcomes.
    Lei Y; Zanker P; Yildiz S; Hancke K; Seidl D; Koch O; Schwentner C; Mundhenk J
    J Endourol; 2019 Feb; 33(2):100-106. PubMed ID: 30526029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.
    Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A
    Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Focal High-intensity Focussed Ultrasound Partial Gland Ablation for the Treatment of Localised Prostate Cancer: A Report of Medium-term Outcomes From a Single-center in the United Kingdom.
    Johnston MJ; Emara A; Noureldin M; Bott S; Hindley RG
    Urology; 2019 Nov; 133():175-181. PubMed ID: 31449831
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Focal HIFU vs robot-assisted total prostatectomy: Functionnal and oncologic outcomes at one year].
    Arnouil N; Gelet A; Matillon X; Rouviere O; Colombel M; Ruffion A; Mège-Lechevallier F; Subtil F; Badet L; Crouzet S
    Prog Urol; 2018 Oct; 28(12):603-610. PubMed ID: 30243461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure.
    Blana A; Brown SC; Chaussy C; Conti GN; Eastham JA; Ganzer R; Murat FJ; Pasticier G; Rebillard X; Rewcastle JC; Robertson CN; Thuroff S; Ward JF
    BJU Int; 2009 Oct; 104(8):1058-62. PubMed ID: 19388986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology.
    Rebillard X; Soulié M; Chartier-Kastler E; Davin JL; Mignard JP; Moreau JL; Coulange C;
    BJU Int; 2008 May; 101(10):1205-13. PubMed ID: 18325057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi-institutional analysis of 418 patients.
    Crouzet S; Blana A; Murat FJ; Pasticier G; Brown SCW; Conti GN; Ganzer R; Chapet O; Gelet A; Chaussy CG; Robertson CN; Thuroff S; Ward JF
    BJU Int; 2017 Jun; 119(6):896-904. PubMed ID: 28063191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes.
    Palermo G; Totaro A; Sacco E; Foschi N; Gulino G; Racioppi M; Bassi P; Pinto F
    Minerva Urol Nefrol; 2017 Feb; 69(1):93-100. PubMed ID: 28009150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
    Thüroff S; Chaussy C
    J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer.
    Inoue Y; Goto K; Hayashi T; Hayashi M
    Int J Urol; 2011 May; 18(5):358-62. PubMed ID: 21449970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.